Research and Clinical Trials
Cedars-Sinai's Liver Research Program is made up of renowned physicians and specialist nurses who are dedicated to advancing the science and practice of hepatology.The hepatology team at Cedars-Sinai is frequently sought out by physicians, scientists, and research and pharmaceutical companies to advise and participate in leading clinical studies. Here at Cedars-Sinai, we currently have one of the broadest range of fully funded research studies for patients with viral hepatitis and other liver diseases.
Clinical research trials allow patients access to the most up-to-date treatments and medications and also advance scientific knowledge. Our expert research nurses and physicians closely supervise the patients throughout the length of the study, and access to medical care is available 24 hours a day. All studies are conducted under the Good Clinical Practice Guidelines and approved by the Cedars-Sinai Institutional Review Board (IRB).
Currently enrolling studies for patients with hepatitis C or hepatitis B include those for people who are treatment naïve (diagnosed with viral hepatitis but have not been treated), and nonresponders and relapsers (previously treated and the virus came back). We also have studies for post-liver-transplant patients with hepatitis. In addition, we are continuing enrollment for a study for HIV-infected patients who need a liver transplant.
We are the only institution in Southern California that is offering transplantation to HIV-infected individuals and one of only a few institutions in the world that is investigating artificial liver devices.
If you are interested in participating in a study or would like to discuss treatment for liver disease, you can contact our research coordinators at:
| Phone: (310) 423-0766 |
| Alt Phone: 1-866-MD4-HEPC (1-866-634-4372) |
| Send Us a Message |
The Team
Fred Poordad, MD is Chief of Hepatology at the Liver Disease and Transplant Center. Dr. Poordad is also an associate professor of medicine at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA).
Dr. Poordad is board certified in internal medicine and gastroenterology. His primary research interests are treatment modalities for hepatitis B, hepatitis C and HIV-related liver diseases. He is also a recognized expert in the field of fatty liver disease.
A prolific national and international lecturer, Dr. Poordad has also written numerous articles for peer-reviewed publications, including American Journal of Transplantation, Clinical Perspectives in Gastroenterology, International Journal of Artificial Organs and Journal of Nephrology. He is a member of the American College of Physicians, American Association for the Study of Liver Disease, American College of Gastroenterology, American Society of Transplantation and the International Liver Transplantation Society.
Dr. Poordad received his bachelor's and medical degrees at the University of Alberta in Edmonton. He completed a residency in internal medicine at St. Thomas Medical Center and Northeastern Ohio Universities College of Medicine. Dr. Poordad also completed fellowships in gastroenterology at the University of South Carolina, Columbia and in hepatology/liver transplantation at Johns Hopkins University School of Medicine.
 Grace Chee, PharmD Clinical Research Coordinator
|
Contact Information
- Grace Chee, PharmD; Phone: (310) 423-5461 Fax: (310) 423-0766
